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ABSTRACT
Objective. The purpose of this study was to retrospectively determine baseline patient characteristics, time-to-hospital 
admission, utilization of reperfusion therapy and outcomes of patients hospitalized with ST-segment elevation acute coro-
nary syndromes (ACS) between 2002 and 2005, particularly after 24-h primary percutaneous coronary intervention (PCI) 
was introduced in 2004.
Methods. Included were all patients admitted to the intensive care unit (ICU) from 2002 to 2005 who met the criteria for ACS. 
Information on patients’ demographic characteristics, medical history, time-to-hospital admission, clinical characteristics on 
admission, laboratory examinations, ECG findings, treatments, hospital duration, and in-hospital outcomes was collected 
by completing a standardized case report form. 
Results. There was a sustained increase in admissions between 2002 and 2005, altogether 899 patients were hospitalized. 
A significant decrease in time-to-hospital admission was achieved. More patients arrived within 4-6 hours (16.3% in 2002 
vs. 31.5% in 2005) and less after 12 hours (35.0% in 2002 vs. 13.4% in 2005). A significant increase in primary PCI rate was 
achieved (16.9% in 2002 vs. 90% in 2005, P<0.001). Consequently, the rate of thrombolysis, postponed PCI and nonreper-
fusion medical therapy decreased. From 2002 to 2005, total in-hospital stay decreased significantly (15.4±13.0 days vs. 
7.8±8.5 days, P<0.001), in-hospital mortality insignificantly (11.3% vs. 7.2%). 
Conclusion. Despite the significant increase in primary PCI between 2002-2005, there was only an insignificant decre-
ase in in-hospital mortality. Further shortening the time-to-hospital admission and increasing primary PCI among older 
hemodynamically unstable ACS patients, particularly those with cardiogenic shock, could achieve an additional decrease 
in mortality. 
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Introduction
Advances in reperfusion therapy have 
contributed to a reduction in mortality 
and reinfarction rates. Both thrombol-
ytic therapy and percutaneous coronary 
intervention may result in successful 
reperfusion of infarct-related arteries 
and lead to a decrease in morbidity and 
mortality. It has become increasingly 
evident that primary Increasingly evi-
dent that primary percutaneous coro-
nary intervention (PCI) could be a supe-
rior reperfusion strategy if performed by 
an experienced team within 90 minutes 
of the first medical contact. (1-3)       
Widespread implementation of rando-
mized clinical trial results and guideli-
nes has been disappointing in the USA 
and Europe. (4-6) Less than 25% of 
USA hospitals have facilities to per-
form primary PCI, and even fewer have 
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24-h availability. There are considerable 
geographic and urban-rural differences 
in quality of care for patients with acute 
myocardial infarction. (7,8) 
In Slovenia the highest prevalence of 
cardiovascular diseases has been 
documented in the eastern region and 
the lowest in the western region of the 
country. Differences were statistically 
significant for stroke, angina pectoris 
and hypertension, but not for myocar-
dial infarction. (9) University Hospital 
Maribor covers an area with approxi-
mately 820,000 inhabitants and has 
the facilities to perform primary PCI 
for the eastern part *of Slovenia. From 
2004 there is 24-h access to primary 
PCI. Our catheterization laboratory and 
and Intensive care unit (ICU) have met 
all the criteria of a high-volume center 
(>200 patients/year and >75 patients/
year per interventional cardiologist). 
Owing to small distances and good 
traffic connections, door to balloon 
time for primary PCI is below 90 minu-
tes for the majority of patients. 
The purpose of this retrospective study 
was to determine baseline patient cha-
racteristics, time from onset of symp-
toms to interventional-hospital admissi-
on, application of reperfusion therapy 
and outcomes of patients hospitalized 
with ST-segment elevation acute coro-
nary syndromes in the years 2002 to 
2005, particularly for the data after 24-h 
primary PCI was introduced in 2004. 
Patients and Methods
Included were all patients admitted to 
the ICU between 2002-2005 with ST-
segment elevation on ECG and who 
met the criteria for acute coronary syn-
drome (ACS). The patients entered in 
the study had to be alive at the time of 
hospital presentation, had to be admit-
ted with ACS as a presumptive diagno-
sis and had to have ST-segment eleva-
tion on ECG. Information on patients’ 
demographic characteristics, medical 
history, time delay between onset of 
symptoms to PCI-hospital arrival, clini-
cal characteristics on admission (Killip 
classes), laboratory findings (troponin 
T, electrolytes, blood glucose, urea, 
creatinine), ECG findings, treatment 
approaches, hospital duration, and in-
hospital outcomes was collected by 
completion of a standardized case 
report form. 
For all patients, the initial diagnosis was 
based on a history of sustained chest 
pain and the finding of ST-elevation on 
initial ECG. ST-elevation myocardial 
infarction (STEMI) was diagnosed as 
persistent angina pectoris for more than 
20 min, ST-segment elevation of more 
than 1 mm in at least two standard leads 
or more than 2 mm in at least two con-
tiguous precordial leads, or the pres-
ence of a left bundle branch block. It 
was later confirmed by an increase of at 
least twice the normal value of troponin 
T. Unstable angina was diagnosed as 
persistent angina pectoris for more than 
20 min, ST-segment elevation, but with 
normal values of troponin T, or a minimal 
increase below twice the normal value. 
The discharge diagnosis was made by 
the attending physician and based on 
the following categories: anterior Q-wave 
myocardial infarction (anterior Q-wave 
MI), nonanterior Q-wave myocardial 
infarction (nonanterior Q-wave MI), non 
Q-wave myocardial infarction (non Q- 
wave MI), and unstable angina (UA).
Time-to-hospital admission was defined 
as the time between the onset of sus-
tained chest pain and admission to the 
emergency department (ED) of Maribor 
hospital.
The Killip class was assigned to each 
patient on the basis of the severity of 
signs of heart failure at first assess-
ment. Killip class I was defined as the 
absence of rales in the lung fields and 
the absence of an S3 heart sound; Killip 
class II was defined as rales in <50% of 
the lung fields, the presence of an S3 or 
jugular venous distension; Killip class 
III was defined as rales in >50% of the 
lung fields and pulmonary edema; and 
Killip class IV was defined as the pres-
ence of cardiogenic shock. Cardiogen-
ic shock was defined as a clinical state 
of sustained hypotension characterized 
by systolic blood pressure of less than 
90 mm Hg, lasting more than 30 min 
with evidence of tissue hypoperfusion 
such as cold and wet skin and oliguria 
<30 mL/h.
Primary PCI was performed in the cath-
eterization laboratory situated close to 
the ED to achieve primary PCI without 
delay. Average door-to-balloon time was 
usually under 30 minutes. Thrombolyt-
ic therapy with Alteplase 100 mg over 
90 minutes was performed in the ICU 
immediately after the patient’s arrival.
The patients received morphine sul-
fate 2 to 4 mg IV, oxygen, sublingual 
nitroglycerin, aspirin (MONA) in refer-
ral hospitals or during emergency 
transport, and oral clopidogrel 300mg, 
IV glycoprotein IIb/IIIa inhibitors and 
unfractionated/LMW heparin in the ED 
or catheterization laboratory if primary 
PCI was planned.
Statistical methods
Statistical analysis was performed with 
the SPSS 12.0 statistical package. 
Percentage distributions, mean values 
and standard deviations were used to 
present background information. The 
ANOVA and chi-square tests were used 
to calculate statistically significant diffe-
rences of background information.
Logistic regression analysis was perfor-
med to calculate the risks associated 
with patient death. The significance, 
odds ratios and confidence intervals 
were calculated for univariate analysis. 
Variables with a significant univariate 
association (P<0.05) with risk of death 
were included in the final multivariate 
binary logistic regression model calcu-
lated by Wald method. Diagnostic rou-
tines (Hosmer-Lemeshow test for lack 
of fit) were used for the final prediction 
model selection. 
Results
Clinical characteristics of patients with 
ST-segment elevation ACS hospitalized 
in the ICU between 2002 and 2005 are 
listed in table 1. There was a sustai-
ned increase of hospitalized patients 
from 2002 to 2005, altogether 899 pati-
ents were hospitalized during the four 
years. There was a similar proportion of 
anterior Q-wave, nonanterior Q-wave, 
non Q-wave MI and UA within different 
years. Time-to-hospital admission was 
available for 784 patients. During the 
four-year period a significant decrea-
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se in time-to-hospital admission was 
achieved. Compared to 2002, in 2005 
more patients arrived within 4-6 hours 
(16.3% vs. 31.5%) and within 7-12 
hours (11.3% vs. 16.8%), and less after 
12 hours (35.0% vs. 13.4%).
Between 2002 and 2006 there was no 
significant difference in Killip classes 
(Killip I/II 85.0% in 2002, vs. 87.5% in 
2005, Killip III/IV 15.0% in 2002 vs. 12.5% 
in 2005). From 2002 to 2005 a significant 

























Male (%) 62.5 68.3 69.7 67.7 67.5 0.478*
Anterior Q-wave MI (%) 51.3 39.3 40.2 38.7 41.5 0.053*
Nonanterior Q-wave MI (%) 44.4 47.0 51.1 53.4 49.8 0.252*
Non-Q MI (%) 1.3 8.7 5.4 5.0 5.2 0.021*
STEMI altogether (%) 97.0 95.0 96.7 97.1 96.5
Unstable angina (%) 3.1 4.9 3.3 2.9 3.5 0.671*
Previous MI (%) 22.5 21.3 10.1 13.3 15.6 <0.001*
Time to hospital admission (N=784)
< 3 hours (%) 37.5 45.4 43.5 38.2 41.1 0.329*
4 – 6 hours (%) 16.3 20.9 26.9 31.5 24.9 0.003*
7 – 12 hours (%) 11.3 12.9 15.7 16.8 14.5 0.395*
> 12 hours (%) 35.0 20.9 13.9 13.4 19.5 <0.001*
Systolic blood pressure (BP) (mmHg) 






































Killip I (%) 54.4 62.3 73.3 69.9 66.6 <0.001*
Killip II (%) 30,6 19.7 16.6 17.6 20.0 0.003*
Killip III (%) 5.0 7.7 4.3 4.3 5.1 0.368*
Killip IV (%) 10.0 10.4 5.8 8.2 8.2 0.262*
Primary PCI (%) 16.9 51.4 83.8 89.9 67.1 <0.001*
Thrombolysis (%) 37.5 18.0 1.1 0.4 10.8 <0.001*
Postponed PCI (%) 8.8 5.5 4.0 2.5 4.7 0.024*
Nonreperfusion medical therapy (%) 36.9 25.1 11.2 7.2 17.4 <0.001*
Coronary artery bypass grafting (CABG) 
during hospitalization (%)
3.1 6.0 1.4 3.2 3.2 0.061*
Previous CABG (%) 1.3 1.1 3.6 1.4 2.0 0.148*
























In hospital mortality (%) 11.3 12.0 8.3 7.2 9.2 0.243*
In hospital mortality without shock (%) 4.9 4.3 5.0 2.0 3.9 0.280*
In hospital mortality Killip I class (%) 3.4 0.0 3.0 1.0 1.8 0.138*
In hospital mortality Killip II class (%) 6.1 11.1 13.0 6.1 8.9 0.547*
In hospital mortality Killip III class (%) 12.5 21.4 8.3 0.0 10.9 0.365*
In hospital mortality Killip IV class (%) 68.8 78.9 62.5 65.2 68.9 0.718*
Anterior Q-wave myocardial infarction (Anterior Q-wave MI), Intensive care unit (ICU), myocardial infarction (MI), Nonanterior Q-wave myo-
cardial infarction (Nonanterior Q-wave MI), Non Q-wave myocardial infarction (Non Q- wave MI), percutaneous coronary intervention (PCI), 
ST-elevation myocardial infarction (STEMI), Unstable angina (UA)
* Chi-square test
+ One-Way ANOVA test
Table 1. Clinical characteristics of patients with ST-segment elevation acute coronary syndromes (ACS) hospital-
ized between 2002 and 2005 (N = 899).
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eved (16.9% vs. 90%); consequently 
thrombolysis, postponed PCI and non-
reperfusion medical therapy rate decre-
ased (37.5% vs. 0.4%; 8.8% vs. 2.5% 
and 36.9% vs. 7.2% respectively).
From 2002 to 2005 there was a signifi-
cant decrease in total in-hospital stay 
(15.4±13.0 days vs. 7.8±8.5 days) 
and a tendency to decrease in-hospital 
mortality (11.3% vs. 7.2%). 
In patients with heart failure the mortality 
rate remained high, particularly in those 
with cardiogenic shock. Total in-hospi-
tal mortality for patients in Killip classes 
II and III was 5 to 6 times higher and in 
Killip class IV even more than 30 times 
higher in comparison with Killip class 
I (table 1). As shown in table 2, non-
survivors were older (72.1 vs. 61.2 yrs, 
P<0.001), with more frequent anterior 
infarction (61.4% vs. 39.5%, P<0.001), 
longer time-to-hospital admission (4-6 
hours 11.1% vs. 26.1%, and >12 hours 





chi-square OR 95% CI p-value
Age (years) 61.2 72.1 45.4 1.08 1.06-1.10 <0.001
Male (%) 68.1 61.4 1.5 0.75 0.47-1.19 0.216
Anterior Q-wave MI (%) 39.5 61.4 14.2 2.44 1.54-3.88 <0.001
Non-anterior Q-wave MI (%) 51.0 37.3 5.5 0.57 0.36-0.91 0.019
Non-Q MI (%)* 5.8 0.0 / / / 0.017
Unstable angina % 3.7 1.2 1.2 0.32 0.04-2.37 0.264
Previous MI (%) 15.0 22.0 2.7 1.60 0.92-2.79 0.098
Time-to-hospital admission 
(N = 784)
< 3 hours (%) 41.2 39.7 0.1 0.94 0.56-1.59 0.815
4 – 6 hours (%) 26.1 11.1 6.4 0.35 0.16-0.79 0.011
7 – 12 hours (%) 14.3 17.5 0.5 1.27 0.64-2.51 0.494
> 12 hours (%) 18.4 31.7 6.3 2.06 1.17-3.61 0.012
Systolic BP (mmHg) 131.4 108.6 39.0 0.97 0.96-0.98 <0.001
Diastolic BP (mmHg) 76.6 63.8 28.1 0.96 0.95-0.98 <0.001
Peak troponin T (g/L) 5.1 6.6 4.6 1.04 1.00-1.08 0.032
Killip I (%) 72.1 13.3 72.0 0.06 0.03-0.11 <0.001
Killip II (%) 20.1 19.3 0.0 0.95 0.54-1.68 0.859
Killip III (%) 5.0 6.0 0.2 1.21 0.47-3.16 0.694
Killip IV (%) 2.8 61.4 167.9 54.95 29.98-100.73 <0.001
Primary-PCI (%) 69.7 41.5 24.8 0.31 0.19-0.49 <0.001
Thrombolysis (%) 10.7 12.2 0.2 1.16 0.58-2.34 0.670
Postponed-PCI (%) 4.9 2.4 1.0 0.49 0.12-2.04 0.324
Non-reperfusion medical 
therapy (%)
14.7 43.9 38.6 4.54 2.82-7.32 <0.001
CABG during 
hospitalization (%)
3.3 2.4 0.2 0.72 0.17-3.09 0.660
Previous CABG (%) 2.1 1.2 0.3 0.57 0.08-4.36 0.591
Hospital stay ICU (days) 2.5 5.9 27.8 1.17 1.10-1.23 <0.001
Total hospital stay (days) 10.9 9.1 2.1 0.98 0.95-1.01 0.151
Anterior Q-wave myocardial infarction (Anterior Q-wave MI), blood pressure (BP), coronary artery bypass grafting (CABG), Intensive care unit 
(ICU), myocardial infarction (MI),  Nonanterior Q-wave myocardial infarction (Nonanterior Q-wave MI), Non Q-wave myocardial infarction (Non 
Q- wave MI), percutaneous coronary intervention (PCI), ST-elevation myocardial infarction (STEMI), Unstable angina (UA)
* Unable to calculate
re (108.6/63.8 mmHg vs. 131.4/76.6 
mmHg, P<0.001), with a great deal of 
Killip class IV at presentation (61.4% 
vs. 2.8%, P<0.001), with less primary 
PCI (41.5% vs. 69.7%, P<0.001), more 
nonreperfusion medical therapy (43.9% 
vs. 14.7%, P<0.001) and longer ICU 
hospital stay (5.9 days vs. 2.5 days, 
P<0.003).
To determine the most significant risk 
factors for death, a multivariate predic-
tion model was calculated with logistic 
Table 2. Comparison of survivors and nonsurvivors with ST-segment elevation acute coronary syndromes ACS hospi-
talized between 2002 and 2005 (N = 899).
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Variable Chi-square OR 95% CI P-value
Age > 65 yrs 20.9 5.83 2.74-12.41 <0.001
Killip I 6.4 0.36 0.17-0.80 0.011
Killip IV 79.0 33.29 15.36-72.11 <0.001
Primary PCI 8.8 0.39 0.21-0.73 0.003
Percutaneous coronary intervention (PCI)
regression using the Wald method. All 
significant variables from the univariate 
analysis presented in table 2 were inclu-
ded in the multivariate prediction model 
calculation. 
The calculated prediction model had a 
specificity of 93.6 % and sensitivity of 
80.7 %. The Hosmer-Lemeshow test 
was not significant, indicating little devi-
ation from perfect fit (chi-square 4.147, 
degrees of freedom 6, P = 0.653). 
The most significant risk factors for 
death were age above 65 years and 
Killip class IV (table 3). When those two 
variables were met, the risk of death 
reached 60% of probability.
The equation based on the prediction 
model allowing an estimation of the 
odds ratios for death was calculated as: 
exp (-3.306 + [1.763 x age > 65 yrs] + 
[-1.102 x Killip class I] + [3.505 x Killip 
class IV] + [-0.944 x Primary PCI]). 
Discussion
From 2002 to 2005 we observed an 
increase in ST-segment elevation ACS 
patients, especially since 24-h primary 
PCI was introduced in 2004, ranging 
from 343 patients in 2002-2003 com-
pared to 556 patients in 2004-2005 
(table1). The increased number of 
admissions to our interventional cen-
ter was the consequence of more 
frequent transfers from referral nonin-
tervention hospitals. In a few years 
our center thus covered an area of 
approximately 820,000 inhabitants. 
Comparing ST-segment elevation 
ACS admissions from 2002 to 2005 
we observed insignificant differences 
in mean age, gender, the incidence of 
anterior Q-wave MI, nonanterior Q-wa-
ve MI, non Q-wave MI and unstable 
angina, and the only significant diffe-
rences in previous MI, more frequently 
in patients before 2004.
Comparing time-to-admission form 
2002 to 2005 we observed that patients 
arrived at the hospital earlier - an enco-
uraging result, which is the consequen-
ce of many factors. Therefore the major 
components of time delay have to be 
analyzed separately: time for patients to 
recognize symptoms and seek medical 
attention, transportation to hospital, in-
hospital decision-making and door-to-
balloon time for primary PCI procedure. 
(2) Physicians and health care systems 
should work to minimize door-to-ballo-
on times and take door-to-balloon time 
into consideration when choosing a 
reperfusion strategy. (10)
For thrombolytic and primary PCI the-
rapy the time to reperfusion is critical. 
There is a positive linear relationship 
between duration of ischemic time 
and poor outcome. In animal models, 
infarct size is significantly affected by 
the duration of coronary occlusion. (11) 
Therefore, late reperfusion is expected 
to result in less myocardial salvage and 
in a higher mortality rate even when 
optimal mechanical reperfusion is achi-
eved. Data from Dutch and some other 
studies show a significant correlation 
between time from symptom onset to 
balloon inflation and mortality. The one-
year mortality is increased by 7.5% for 
each 30-minute delay. (12) In patients 
with STEMI treated by primary angi-
oplasty, symptom-onset-to-balloon 
time - but not door-to-balloon time - 
is related to mortality, particularly in 
higher-risk patients and in the absence 
of preprocedural anterograde flow. (13) 
Prolonged ischemic time is associa-
ted with higher mortality, mainly due 
to impaired myocardial perfusion and 
larger infarct size. (14)
After 2004, primary PCI became the 
main reperfusion strategy in our institu-
tion. In 2005, thrombolysis was perfor-
med only once when the interventional 
equipment broke down for a brief peri-
od. The increase of primary PCI in com-
parison to thrombolytic and nonreper-
fusion medical therapy after 2004 is an 
important achievement, namely primary 
PCI is more effective for treating STEMI, 
(15) if the transport to an interventional-
hospital takes two hours or less. (16) In 
addition, facilitated percutaneous inter-
vention offers no benefit over primary 
PCI. (17) One of the important advanta-
ges of   24-hour access to primary PCI 
is a significantly shorter mean in-hos-
pital stay. The decrease of in-hospital 
stay together with the improved quality 
of life of numerous ST-segment ele-
vation ACS patients after primary PCI 
can exert an important impact on the 
health care budget. We also noted an 
in-hospital mortality reduction that did 
not reach statistical significance. 
Comparing survivors and nonsur-
vivors we observed that primary PCI 
was significantly more likely performed 
in survivors than in nonsurvivors. The 
causes for underused primary PCI in 
nonsurvivors are different and various. 
Most often symptomatic treatment of 
life-threatening events, such as cardio-
pulmonary resuscitation in case of car-
diac arrest, orotracheal intubation with 
subsequent mechanical ventilation in 
case of respiratory arrest due to shock, 
delays the arrival to the catheterization 
laboratory, thus causing a substantial 
delay in salvation of the jeopardized 
myocardium. In cases with unsucce-
ssful resuscitation with death in most 
severely affected patients, primary PCI 
is not even started, and such cases are 
classified as having been treated nonin-
vasively. In addition, late admissions 
due to ST-segment elevation ACS are 
generally neither treated with reperfusi-
on therapy nor with primary PCI. 
We observed that reperfusion thera-
py with primary PCI was significantly 
underused in nonsurvivors, particularly 
those with cardiogenic shock – Killip 
class IV, thus confirming indirectly the 
conclusions of other studies evaluating 
the mode of therapy among STEMI 
patients with cardiogenic shock, which 
demonstrated poor implementation of 
Table 3. Variables independently related to risk of death.
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recent guidelines advocating an aggre-
ssive invasive approach. (18,19) Based 
on the results of the SHOCK trial, (20) 
and guidelines for the management of 
ST-elevation ACS, (2,3) primary PCI 
was advocated as the reperfusion the-
rapy of choice for patients with cardio-
genic shock. Moreover, the guidelines 
recommended the use of intra-aortic 
balloon pump counterpulsation (IABP) 
among hemodynamically unstable ACS 
patients, especially those with cardio-
genic shock. 
Within the last few years a lot of effort 
was necessary to implement contem-
porary treatment guidelines for STEMI 
patients at our institution, to which pati-
ents from the entire Maribor area and 
including those from five regional hos-
pitals are referred, with transfer distan-
ces not exceeding 100 km. However, 
late treatment - especially in patients 
with extensive infarctions – contributes 
significantly to mortality.   
The time delay at the start of therapy is 
in part the consequence of negligence 
on the part of the patient, underevalua-
tion of symptoms of acute myocardial 
infarction, but also the result of unne-
cessary waiting in emergency depar-
tments prior to hospital admission, 
repetition of laboratory tests, prolonged 
waiting for adequate transportation to 
an interventional center, etc. 
The average prehospital delay in the 
USA is several hours, and the majority 
of this delay comes from the patient’s 
delaying seeking medical attention. 
(21) Our observations suggest that the 
introduction of primary PCI claims chan-
ges in the organization of the medical 
services, including family practitioners, 
emergency medical services, hospitals, 
referral and interventional centers per-
forming primary PCI. (22) Apart from 
resources, a sufficient number of trai-
ned medical staff is necessary to satisfy 
the needs of patients with acute evol-
ving myocardial infarction. (23,24)
Conclusions
After 2004 the patients arrived to hos-
pital earlier and primary PCI became 
the main reperfusion therapy. In pati-
ents with heart failure the mortality rate 
remained high, particularly in those with 
cardiogenic shock. An additional decre-
ase in mortality could be achieved by 
further shortening the time-to-hospital 
admission and increasing primary PCI 
among older hemodynamically unsta-
ble ACS patients, particularly those with 
Killip class IV at first assessment.
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